Anti-Oxidative Effect of Myrtenal in Prevention and Treatment of Colon Cancer Induced by 1, 2-Dimethyl Hydrazine (DMH) in Experimental Animals.
Colon cancer is considered as the precarious forms of cancer in many developed countries, with few to no symptoms; the tumor is often diagnosed in the later stages of cancer. Monoterpenes are a major part of plant essential oils found largely in fruits, vegetables and herbs. The cellular and molecular activities show therapeutic progression that may reduce the risk of developing cancer by modulating the factors responsible for colon carcinogenesis. Colon cancer was induced with DMH with a dose of (20 mg/Kg/body weight) for 15 weeks by subcutaneous injection once in a week. Myrtenal treatment was started with (230 mg/Kg/body weight) by intragastric administration, one week prior to DMH induction and continued till the experimental period of 30 weeks. The Invivo results exhibit the elevated antioxidant and lipid peroxidation levels in DMH treated animals. The Histopathological analysis of colon tissues well supported the biochemical alterations and inevitably proves the protective role of Myrtenal. Treatment with myrtenal to cancer bearing animals resulted in a remarkable increase in the inherent antioxidants and excellent modulation in the morphological and physiological nature of the colon tissue. It is thus concluded that myrtenal exhibits excellent free radical scavenging activity and anticancer activity through the suppression of colon carcinoma in Wistar albino rats.
Department of Pharmacology and Environmental Toxicology, Dr. A. L. MPGIBMS, University of Madras, Taramani Campus, Chennai- 600 113, Tamilnadu, India.
Booupathy
B
Lokeshkumar
Department of Pharmacology and Environmental Toxicology, Dr. A. L. MPGIBMS, University of Madras, Taramani Campus, Chennai- 600 113, Tamilnadu, India.
Venkatachalam
V
Sathishkumar
Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Natarajan
N
Nandakumar
Department of chemical pathology, Universiti Sains Malaysia Kubang Kerian, Kelantan Malaysia 16150.
Thamaraiselvan
T
Rengarajan
Center for Nanoscience and Nanotechnology, Sathyabama University, Jeppiaar Nagar, Chennai -600119, Tamilnadu, India.
Arumugam
A
Madankumar
Department of Pharmacology and Environmental Toxicology, Dr. A. L. MPGIBMS, University of Madras, Taramani Campus, Chennai- 600 113, Tamilnadu, India.
Maruthaiveeran Periyasamy
MP
Balasubramanian
Antioxidants; Colon cancer; DMH; Monoterpenes; Myrtenal